IFNL2 and asthma: However IFN-λ2 expression was upregulated by 43.5% and 49.1% in AR, by 125% and 42.3% in asthma, and by 99% and 72.8% in AR + AS in cytotoxic T cells and eosinophils but downregulated by 57% and 76.3% in AR, by 86.4% and 81.6% in asthma, and by 58.1% and 37.2% in AR + AS in monocytes and neutrophils, respectively (Figure 2(b)).